Literature DB >> 23657181

Acute leg ischaemia.

Stephen Brearley1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23657181     DOI： 10.1136/bmj.f2681

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  4-Phenylbutyric acid protects against vasculitic peripheral neuropathy induced by ischaemia-reperfusion through attenuating endoplasmic reticulum stress.

Authors:  Cay-Huyen Chen; Ping-Chen Shih; Han-Yu Lin; Po-Kai Wang; Po-Ting Pan; Ching-Wei Chuang; Ming-Chang Kao
Journal:  Inflammopharmacology       Date:  2019-05-22       Impact factor: 4.473

2.  Toe necrosis: report of uncommon aetiology.

Authors:  Siham Mansouri; Ayoub Bounsir; Laila Benzekri; Badr Hassam
Journal:  BMJ Case Rep       Date:  2019-07-12

3.  Toe Necrosis, Etiologies and Management, a Case Series.

Authors:  Abdelfatah Abou Issa; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2014-09-28

4.  Diagnosis of abdominal mural aortic thrombus following discovery of common femoral artery and vein thrombosis by point-of-care ultrasound.

Authors:  Nadia Maria Shaukat; Farook Taha; Eugene Vortsman; Poonam Desai; Mark Kindschuh
Journal:  J Ultrasound       Date:  2015-10-06

Review 5.  Autoamputation of diabetic toe with dry gangrene: a myth or a fact?

Authors:  Abdullah Al Wahbi
Journal:  Diabetes Metab Syndr Obes       Date:  2018-06-01       Impact factor: 3.168

6.  Predictive Factors for Post-Ischemic Compartment Syndrome in Non-Traumatic Acute Limb Ischemia in a Lower Extremity.

Authors:  Saritphat Orrapin; Saranat Orrapin; Supapong Arwon; Kittipan Rerkasem
Journal:  Ann Vasc Dis       Date:  2017-12-25

7.  Acute limb ischemia in a cancer patient has high morbidity, high mortality, and atypical presentation: a tertiary cancer center's retrospective study.

Authors:  Yolanda Bryce; Amoateng Emmanuel; Christopher Agrusa; Etay Ziv; Christopher Harnain; Samantha Huq; Ernesto Santos Martin
Journal:  BMC Cancer       Date:  2021-08-13       Impact factor: 4.430
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.